Get the Stockscreener App
3.51
3.31%
-0.12
Nasus Pharma Ltd. Stock (NSRX) Forecast
The Nasus Pharma Ltd. (NSRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.0383, representing a -13.44% decrease from the current price of $3.51. The highest analyst price target is $4.1945, and the lowest is $1.882.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NSRX Price Target
Average 2.8316
(-19.33% Downside)
Is Nasus Pharma Ltd. (NSRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.09 | Neutral |
| STOCH(9,6) | 52.10 | Neutral |
| STOCHRSI(14) | 26.55 | Neutral |
| MACD(12,26) | 0.0223 | Sell |
| ADX(14) | 18.12 | Neutral |
| William %R | -78.67 | Neutral |
| CCI(14) | -70.12 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.719
Sell
|
3.6818
Sell
|
| MA20 |
3.628
Sell
|
3.6679
Sell
|
| MA50 |
3.6394
Sell
|
3.5923
Sell
|
| MA100 |
3.3757
Buy
|
3.6189
Sell
|
| MA200 |
3.9749
Sell
|
4.4029
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, NSRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on NSRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.09 indicates that NSRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 52.1 indicates that NSRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.55 indicates that NSRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.12 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -70.12 indicates that NSRX is still oversold but not to an extreme extent.
Long-term NSRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nasus Pharma Ltd. financial reports and earnings history, Nasus Pharma Ltd. (NSRX) stock could reach $4.544 by 2030, $42.03 by 2040 and $58.56 by 2050. See the projected annual prices until 2050 of the Nasus Pharma Ltd. stock below:
- Nasus Pharma Ltd. (NSRX) is expected to reach an average price of $10.56 in 2035, with a high prediction of $11.41 and a low estimate of $10.60. This indicates an $200.98% rise from the last recorded price of $3.51.
- Nasus Pharma Ltd. (NSRX) stock is projected to chart a bullish course in 2040, with an average price target of $41.23, representing an $1,075% surge from its current level. The forecast ranges from a conservative $41.88 to a sky-high $42.03.
- Our analysts predict Nasus Pharma Ltd. (NSRX) to jump 1,345% by 2045, soaring from $51.59 to an average price of $50.72, potentially reaching $51.79. While $51.59 is the low estimate, the potential upside is significant.
- Nasus Pharma Ltd. (NSRX) stock is expected to climb by 2050, reaching an average of $56.01, a $1,496% jump from its current level. However, a wide range of estimates exists, with high and low targets of $58.56 and $56.29, respectively, highlighting the market's uncertainty.
Nasus Pharma Ltd. Stock (NSRX) Year by Year Forecast
Nasus Pharma Ltd. Stock (NSRX) Price Forecast for 2026
The predicted value for Nasus Pharma Ltd. (NSRX) in 2026 is set at an average of $5.4553. Estimates vary from a peak of $9.44 to a trough of $1.4706, indicating an +55.42% surge from the present price of $3.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $3.2945 | $1.882 | $4.1945 | -6.14% |
| December, 2026 | $2.7571 | $2.1758 | $3.7852 | -21.45% |
Nasus Pharma Ltd. Stock (NSRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nasus Pharma Ltd. (NSRX) is $2.8316, with a high forecast of $5.6197 and a low forecast of $0.0435. This indicates an -19.33% decrease from the last price of $3.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.2697 | $2.0884 | $5.6197 | +50.13% |
| February, 2027 | $2.5323 | $2.5323 | $5.6003 | -27.86% |
| March, 2027 | $1.2755 | $0.9955 | $2.9148 | -63.66% |
| April, 2027 | $1.1419 | $0.5161 | $1.7668 | -67.47% |
| May, 2027 | $0.4513 | $0.9287 | $1.3413 | -87.14% |
| June, 2027 | $0.0961 | $0.1661 | $0.4919 | -97.26% |
| July, 2027 | $0.0565 | $0.0435 | $0.8174 | -98.39% |
| August, 2027 | $0.3097 | $0.0871 | $1.0197 | -91.18% |
| September, 2027 | $0.9973 | $0.3314 | $1.1423 | -71.59% |
| October, 2027 | $1.7888 | $0.6329 | $1.8048 | -49.04% |
| November, 2027 | $1.5981 | $0.9461 | $1.9081 | -54.47% |
| December, 2027 | $2.2487 | $1.4294 | $2.0487 | -35.93% |
Nasus Pharma Ltd. Stock (NSRX) Price Forecast for 2028
In 2028, Nasus Pharma Ltd. (NSRX) is projected to reach an average price of $2.376, with a high projection of $4.3926 and a low estimate of $0.3593. This indicates an -32.31% fall from the last price of $3.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.7123 | $0.9823 | $2.0074 | -79.71% |
| February, 2028 | $1.1671 | $0.911 | $1.1671 | -66.75% |
| March, 2028 | $0.2369 | $1.4419 | $0.6058 | -93.25% |
| April, 2028 | $0.4668 | $0.3593 | $1.7607 | -86.70% |
| May, 2028 | $1.2103 | $1.1855 | $1.1716 | -65.52% |
| June, 2028 | $4.1152 | $2.519 | $2.9852 | +17.24% |
| July, 2028 | $4.1387 | $4.2613 | $4.3926 | +17.91% |
| August, 2028 | $2.9035 | $3.4485 | $3.1949 | -17.28% |
| September, 2028 | $2.7984 | $2.7984 | $2.8297 | -20.27% |
| October, 2028 | $1.8219 | $1.8219 | $2.3471 | -48.09% |
| November, 2028 | $1.9668 | $2.0368 | $1.9643 | -43.97% |
| December, 2028 | $0.5716 | $0.9066 | $1.3155 | -83.72% |
Nasus Pharma Ltd. Stock (NSRX) Price Forecast for 2029
The 2029 price forecast for Nasus Pharma Ltd. Stock (NSRX) is $4.0232 on average, with a high prediction of $7.7039 and a low estimate of $0.3426. This represents an +14.62% increase from the previous price of $3.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7851 | $0.7203 | $0.5464 | -77.63% |
| February, 2029 | $5.47 | $0.3426 | $5.22 | +55.84% |
| March, 2029 | $5.1523 | $5.4623 | $6.4161 | +46.79% |
| April, 2029 | $5.1226 | $5.1164 | $4.9703 | +45.94% |
| May, 2029 | $4.3093 | $5.5181 | $5.2506 | +22.77% |
| June, 2029 | $4.2971 | $4.199 | $3.4829 | +22.42% |
| July, 2029 | $4.8874 | $4.2852 | $4.7938 | +39.24% |
| August, 2029 | $5.2997 | $5.7655 | $5.2216 | +50.99% |
| September, 2029 | $7.4619 | $7.5319 | $7.7039 | +112.59% |
| October, 2029 | $6.4522 | $6.6022 | $7.238 | +83.82% |
| November, 2029 | $5.3545 | $5.9045 | $5.7984 | +52.55% |
| December, 2029 | $4.6048 | $4.7929 | $5.1706 | +31.19% |
Nasus Pharma Ltd. Stock (NSRX) Price Forecast for 2030
Nasus Pharma Ltd. Stock (NSRX) is expected to reach an average price of $6.7045 in 2030, with a high forecast of $11.02 and a low forecast of $2.3938. This signifies an +91.01% surge from the last price of $3.51.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.4971 | $4.4829 | $4.544 | +28.12% |
| February, 2030 | $3.1293 | $3.9793 | $4.2451 | -10.85% |
| March, 2030 | $3.2367 | $3.0155 | $2.9074 | -7.79% |
| April, 2030 | $2.5219 | $2.3938 | $2.7196 | -28.15% |
| May, 2030 | $9.7723 | $10.46 | $10.82 | +178.41% |
| June, 2030 | $9.3219 | $9.3219 | $9.3697 | +165.58% |
| July, 2030 | $9.209 | $9.561 | $9.3342 | +162.37% |
| August, 2030 | $7.8087 | $8.0387 | $7.9264 | +122.47% |
| September, 2030 | $9.1058 | $8.0435 | $8.4709 | +159.42% |
| October, 2030 | $9.0355 | $9.3206 | $8.6955 | +157.42% |
| November, 2030 | $11.03 | $9.6229 | $11.02 | +214.11% |
| December, 2030 | $9.7322 | $10.02 | $10.46 | +177.27% |
6.05%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):